Eltrombopag Interactions
There are 186 drugs known to interact with eltrombopag, along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 22 are major, 161 are moderate, and 3 are minor.
- View all 186 medications that may interact with eltrombopag
- View eltrombopag alcohol/food interactions (2)
- View eltrombopag disease interactions (4)
Most frequently checked interactions
View interaction reports for eltrombopag and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Abelcet (amphotericin b lipid complex)
- Aclasta (zoledronic acid)
- Aleve (naproxen)
- Aspirin Low Strength (aspirin)
- Atacand HCT (candesartan / hydrochlorothiazide)
- Atrovent (ipratropium)
- Avodart (dutasteride)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Carbatrol (carbamazepine)
- Cialis (tadalafil)
- Cipro (ciprofloxacin)
- Ciprodex (ciprofloxacin / dexamethasone otic)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Ethyl Alcohol (ethanol)
- Jardiance (empagliflozin)
- Paracetamol (acetaminophen)
- Rituxan (rituximab)
- Tramadol Hydrochloride ER (tramadol)
- Urso (ursodiol)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Votrient (pazopanib)
Eltrombopag alcohol/food interactions
There are 2 alcohol/food interactions with eltrombopag.
Eltrombopag disease interactions
There are 4 disease interactions with eltrombopag which include:
- hepatitis C
- hepatotoxicity / hepatic dysfunction
- cataracts
- thrombotic / thromboembolic complications
More about eltrombopag
- eltrombopag consumer information
- Compare alternatives
- Reviews (23)
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet-stimulating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.